Real-world retrospective observational study exploring the effectiveness and safety of antifibrotics in idiopathic pulmonary fibrosis

BACKGROUND: Pirfenidone and nintedanib are the only disease-modifying treatments available for idiopathic pulmonary fibrosis (IPF). Our aim was to test their effectiveness and safety in clinical practice. METHODS: This is a single-centre retrospective observational study undertaken at a specialised...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMJ Open Respir Res
Hlavní autoři: Wright, William Alexander, Crowley, Louise E, Parekh, Dhruv, Crawshaw, Anjali, Dosanjh, Davinder P, Nightingale, Peter, Thickett, David R
Médium: Artigo
Jazyk:Inglês
Vydáno: BMJ Publishing Group 2021
Témata:
Interstitial Lung Disease
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8006845/
https://ncbi.nlm.nih.gov/pubmed/33771813
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjresp-2020-000782
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky